Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma.

AIM To investigate the prevalence and time of Dickkopf (DKK) family methylation and its clinical significance in hepatocarcinogenesis. METHODS Methylation of DKK family genes was quantitatively analyzed in 115 liver tissue samples, including 50 pairs of primary hepatocellular carcinoma (HCC) and matched noncancerous cirrhotic tissue samples, as well as 15 liver cirrhosis biopsy samples. RESULTS The methylation level of DKK3 was significantly higher in HCC tissue samples than in matched noncancerous cirrhotic tissue samples (P < 0.0001) or in liver cirrhosis biopsy samples (P = 0.0139). Receiver operator characteristic curve analysis confirmed that the percent of methylated reference (PMR) values of DKK3 could effectively discriminate HCC tissue samples from noncancerous tissue samples (AUC = 0.8146) or liver cirrhosis biopsy samples (AUC = 0.7093). Kaplan-Meier survival curves revealed that the progression-free survival time of patients with a higher DKK3 methylation level (PMR > 1%) was significantly shorter than that of those with a lower DKK3 methylation level (PMR < or = 1%) (P = 0.0255). Multivariate Cox analysis indicated that methylated DKK3 was significantly and independently related with a shorter survival time (relative risk = 2.527, 95% CI: 1.063-6.008, P = 0.036) of HCC patients. CONCLUSION Methylation of DKK3 is an important event in early malignant transformation and HCC progression, and therefore might be a prognostic indicator for risk assessment of HCC.

[1]  Q. Xiong,et al.  Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma. , 2009, World journal of gastroenterology.

[2]  Yi-jun Wang,et al.  Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin , 2009, Cancer science.

[3]  S. Nomoto,et al.  Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver , 2008, International journal of cancer.

[4]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[5]  J. Chung,et al.  Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines. , 2008, Gynecologic oncology.

[6]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[7]  C. Boland,et al.  Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma , 2008, Hepatology.

[8]  Raimund Margreiter,et al.  Dickkopf-3 As a New Potential Marker for Neoangiogenesis in Colorectal Cancer: Expression in Cancer Tissue and Adjacent Non-Cancerous Tissue , 2008, Disease markers.

[9]  H. Sugimoto,et al.  Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma , 2007, British Journal of Cancer.

[10]  S. Thorgeirsson,et al.  Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. , 2007, The Journal of clinical investigation.

[11]  K. Ando,et al.  Preferential hypermethylation of the Dickkopf‐1 promoter in core‐binding factor leukaemia , 2007, British journal of haematology.

[12]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[13]  W. Coleman,et al.  The Use of Epigenetic Biomarkers for Preclinical Detection of Hepatocellular Carcinoma: Potential for Noninvasive Screening of High-Risk Populations , 2007, Clinical Cancer Research.

[14]  C. Niehrs,et al.  Function and biological roles of the Dickkopf family of Wnt modulators , 2006, Oncogene.

[15]  M. Fraga,et al.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer , 2006, Oncogene.

[16]  B. Leggett,et al.  Review of genetic and epigenetic alterations in hepatocarcinogenesis , 2006, Journal of gastroenterology and hepatology.

[17]  A. Lok,et al.  Management of patients with hepatitis B virus-induced cirrhosis. , 2005, Journal of hepatology.

[18]  Sen-Yung Hsieh,et al.  Dickkopf-3/REIC functions as a suppressor gene of tumor growth , 2004, Oncogene.

[19]  P. Laird,et al.  Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. , 2000, Cancer research.

[20]  P. Laird,et al.  Adenocarcinoma Epigenetic Patterns in the Progression of Esophageal Updated Version , 2001 .

[21]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.